Short Interest in Amdocs Limited (NASDAQ:DOX) Rises By 9.5%

Amdocs Limited (NASDAQ:DOX - Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,070,000 shares, a growth of 9.5% from the March 31st total of 1,890,000 shares. Currently, 1.8% of the company's stock are sold short. Based on an average trading volume of 673,100 shares, the short-interest ratio is presently 3.1 days.

Analyst Upgrades and Downgrades

A number of brokerages have commented on DOX. Barclays boosted their price target on shares of Amdocs from $105.00 to $115.00 and gave the company an "overweight" rating in a research note on Thursday, February 8th. Citigroup raised their target price on Amdocs from $96.00 to $104.00 and gave the company a "buy" rating in a report on Wednesday, January 17th. Finally, StockNews.com downgraded Amdocs from a "strong-buy" rating to a "buy" rating in a report on Friday, March 15th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $108.60.

Check Out Our Latest Research Report on DOX

Institutional Investors Weigh In On Amdocs

Hedge funds and other institutional investors have recently modified their holdings of the stock. Norges Bank bought a new position in Amdocs in the 4th quarter worth about $119,694,000. Acadian Asset Management LLC purchased a new stake in Amdocs in the third quarter worth approximately $96,934,000. Invesco Ltd. raised its stake in shares of Amdocs by 31.0% during the third quarter. Invesco Ltd. now owns 2,629,346 shares of the technology company's stock worth $222,153,000 after acquiring an additional 621,962 shares in the last quarter. Qube Research & Technologies Ltd lifted its holdings in shares of Amdocs by 333.7% in the 3rd quarter. Qube Research & Technologies Ltd now owns 449,788 shares of the technology company's stock worth $38,003,000 after acquiring an additional 346,071 shares during the last quarter. Finally, Seizert Capital Partners LLC bought a new position in shares of Amdocs during the 4th quarter valued at $28,059,000. 92.02% of the stock is currently owned by institutional investors.


Amdocs Stock Performance

Shares of NASDAQ DOX traded down $0.88 during midday trading on Tuesday, reaching $83.99. The company's stock had a trading volume of 672,458 shares, compared to its average volume of 648,039. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.29 and a quick ratio of 1.29. The stock has a market capitalization of $9.87 billion, a P/E ratio of 17.96, a PEG ratio of 1.38 and a beta of 0.69. The firm has a 50 day moving average price of $89.50 and a 200-day moving average price of $87.41. Amdocs has a 12-month low of $78.38 and a 12-month high of $99.75.

Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The business had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. During the same period in the prior year, the firm earned $1.33 earnings per share. The company's revenue was up 5.0% compared to the same quarter last year. As a group, equities analysts predict that Amdocs will post 5.87 earnings per share for the current year.

Amdocs Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 26th. Shareholders of record on Friday, March 29th were paid a $0.479 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $1.92 annualized dividend and a yield of 2.28%. This is an increase from Amdocs's previous quarterly dividend of $0.44. Amdocs's dividend payout ratio (DPR) is currently 41.11%.

Amdocs Company Profile

(Get Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Recommended Stories

Should you invest $1,000 in Amdocs right now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

Search Headlines: